Cargando…

Correction: Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis

Detalles Bibliográficos
Autores principales:	Mah, Way-Champ, Thurnherr, Thomas, Chow, Pierce K. H., Chung, Alexander Y. F., Ooi, London L. P. J., Toh, Han Chong, Teh, Bin Tean, Saunthararajah, Yogen, Lee, Caroline G. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713443/ https://www.ncbi.nlm.nih.gov/pubmed/26751067 http://dx.doi.org/10.1371/journal.pone.0146690

Ejemplares similares

Methylation Profiles Reveal Distinct Subgroup of Hepatocellular Carcinoma Patients with Poor Prognosis
por: Mah, Way-Champ, et al.
Publicado: (2014)

Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways
por: Thurnherr, Thomas, et al.
Publicado: (2016)

DNA methylation: potential biomarker in Hepatocellular Carcinoma
por: Mah, Way-Champ, et al.
Publicado: (2014)

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Targeting sickle cell disease root-cause pathophysiology with small molecules
por: Saunthararajah, Yogen
Publicado: (2019)

Mysteries of partial dihydroorotate dehydrogenase inhibition and leukemia terminal differentiation
por: Saunthararajah, Yogen
Publicado: (2020)

Clinicopathological-Associated Regulatory Network of Deregulated circRNAs in Hepatocellular Carcinoma
por: Han, Jian, et al.
Publicado: (2021)

Personalized quantitative models of NAD metabolism in hepatocellular carcinoma identify a subgroup with poor prognosis
por: Chedere, Adithya, et al.
Publicado: (2022)

Severe pyoderma gangrenosum caused by myelodysplastic syndrome successfully treated with decitabine administered by a noncytotoxic regimen
por: Saleh, Mostafa F. M., et al.
Publicado: (2017)

5-aza-2′,2′-Difluroro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
por: Daifuku, Richard, et al.
Publicado: (2017)

Silibinin down-regulates FAT10 and modulate TNF-α/IFN-γ-induced chromosomal instability and apoptosis sensitivity
por: Gao, Yun, et al.
Publicado: (2015)

Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2020)

Highly deregulated lncRNA LOC is associated with overall worse prognosis in Hepatocellular Carcinoma patients
por: Lim, Lee Jin, et al.
Publicado: (2021)

Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
por: Enane, Francis O., et al.
Publicado: (2018)

Mutational interactions define novel cancer subgroups
por: Kuipers, Jack, et al.
Publicado: (2018)

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
por: Ebrahem, Quteba, et al.
Publicado: (2012)

Identification of Anoikis-Related Subgroups and Prognosis Model in Liver Hepatocellular Carcinoma
por: Chen, Yutong, et al.
Publicado: (2023)

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
por: Garnelo, Marta, et al.
Publicado: (2017)

MicroRNA-224 Targets SMAD Family Member 4 to Promote Cell Proliferation and Negatively Influence Patient Survival
por: Wang, Yu, et al.
Publicado: (2013)

Neutrophils: driving progression and poor prognosis in hepatocellular carcinoma?
por: Margetts, Jane, et al.
Publicado: (2018)

Infiltration of a Unique CD8(+)CD274(+) Cell Subgroup in Hepatocellular Carcinoma is Associated with Poor Clinical Outcomes
por: Zhang, Yong, et al.
Publicado: (2023)

[(18)F] Clofarabine for PET Imaging of Hepatocellular Carcinoma
por: Sergeeva, Olga, et al.
Publicado: (2019)

Distinct symptom experiences in subgroups of patients with COPD
por: Christensen, Vivi L, et al.
Publicado: (2016)

Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroups
por: Gomez-Bougie, Patricia, et al.
Publicado: (2014)

Expression of HIF-1α in medullary thyroid cancer identifies a subgroup with poor prognosis
por: Lodewijk, Lutske, et al.
Publicado: (2017)

ATRT-12. LIN28A expression correlates with poor prognosis and the MYC subgroup in AT/RTs
por: Dottermusch, Matthias, et al.
Publicado: (2022)

Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction
por: Uchida, Naoya, et al.
Publicado: (2014)

Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions
por: Zavras, Phaedon D., et al.
Publicado: (2021)

DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway
por: Karan, Dev, et al.
Publicado: (2023)

Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma
por: Triozzi, Pierre L., et al.
Publicado: (2016)

A non‐cytotoxic regimen of decitabine to treat refractory T‐cell large granular lymphocytic leukemia
por: Zawit, Misam, et al.
Publicado: (2021)

Rare FGFR fusion genes in cervical cancer and transcriptome‐based subgrouping of patients with a poor prognosis
por: Hiranuma, Kengo, et al.
Publicado: (2023)

Novel mutations target distinct subgroups of medulloblastoma
por: Robinson, Giles, et al.
Publicado: (2012)

Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma
por: Zhang, Zhengwei, et al.
Publicado: (2023)

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies
por: Leclair, Valérie, et al.
Publicado: (2023)

Tracking Decitabine Incorporation into Malignant Myeloid Cell DNA in vitro and in vivo by LC-MS/MS with Enzymatic Digestion
por: Chilakala, Sujatha, et al.
Publicado: (2019)

Changing paradigms in oncology: Toward noncytotoxic treatments for advanced gliomas
por: von Knebel Doeberitz, Nikolaus, et al.
Publicado: (2022)

The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma
por: Ang, Soo Fan, et al.
Publicado: (2015)

Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
por: ZHANG, ZHEN-HAI, et al.
Publicado: (2014)

Decrease of Fibulin-3 in Hepatocellular Carcinoma Indicates Poor Prognosis
por: Luo, Rongzhen, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_u7u57bbrun3km0sdfmkohpr0ht